Frequentist Approaches to Interim Monitoring of Clinical Trials: A Review of Recent Theoretical Developments

[1]  A. Gould,et al.  Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance , 1992 .

[2]  J. Berger.  Statistical Decision Theory and Bayesian Analysis , 1988 .

[3]  J. Peto,et al.  Asymptotically Efficient Rank Invariant Test Procedures , 1972 .

[4]  Scott S. Emerson,et al.  Statistical Packages for Group Sequential Methods , 1996 .

[5]  S J Pocock,et al.  Interim analyses for randomized clinical trials: the group sequential approach. , 1982, Biometrics.

[6]  Herman Chernoff,et al.  Sequential medical trials involving paired data , 1981 .

[7]  Nancy L. Geller,et al.  Design of Group Sequential Clinical Trials with Multiple Endpoints , 1989 .

[8]  A. Gould.  Planning and revising the sample size for a trial. , 1995, Statistics in Medicine.

[9]  Anastasios A. Tsiatis,et al.  Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , 1982 .

[10]  I. Bross,et al.  Sequential Medical Plans. , 1952 .

[11]  David L. DeMets,et al.  An overview of sequential methods and their application in clinical trials , 1984 .

[12]  R J Cook,et al.  Guidelines for monitoring efficacy and toxicity responses in clinical trials. , 1994, Biometrics.

[13]  James H. Ware,et al.  On distribution-free tests for equality of survival distributions , 1977 .

[14]  N L Geller,et al.  On the choice of times for data analysis in group sequential clinical trials. , 1991, Biometrics.

[15]  D. Zucker,et al.  Sequential monitoring of clinical trials: the role of information and Brownian motion. , 1993, Statistics in medicine.

[16]  D J Spiegelhalter,et al.  Comparison of Bayesian with group sequential methods for monitoring clinical trials. , 1989, Controlled clinical trials.

[17]  Anastasios A. Tsiatis,et al.  Repeated significance testing in longitudinal clinical trials , 1996 .

[18]  D L DeMets,et al.  The alpha spending function approach to interim data analyses. , 1995, Cancer treatment and research.

[19]  J. Whitehead.  Overrunning and underrunning in sequential clinical trials. , 1992, Controlled Clinical Trials.

[20]  D J Spiegelhalter,et al.  The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee. , 1994, Statistics in medicine.

[21]  M D Hughes,et al.  Practical problems in interim analyses, with particular regard to estimation. , 1989, Controlled clinical trials.

[22]  R. Madsen,et al.  P values for tests using a repeated significance test design , 1982 .

[23]  S. Pocock.  Group sequential methods in the design and analysis of clinical trials , 1977 .

[24]  Thomas Sellke,et al.  Sequential analysis of the proportional hazards model , 1983 .

[25]  B P Carlin,et al.  Robust Bayesian approaches for clinical trial monitoring. , 1996, Statistics in medicine.

[26]  D A Berry,et al.  Decision making during a phase III randomized controlled trial. , 1994, Controlled clinical trials.

[27]  Christopher Jennison,et al.  Efficient group sequential tests with unpredictable group sizes , 1987 .

[28]  D. Spiegelhalter,et al.  The Assessment of the Subjective Opinion and its Use in Relation to Stopping Rules for Clinical Trials , 1983 .

[29]  D I Tang,et al.  On the design and analysis of randomized clinical trials with multiple endpoints. , 1993, Biometrics.

[30]  Donald B. Rubin,et al.  Sensitivity of Bayes Inference with Data-Dependent Stopping Rules , 1984 .

[31]  Sung C. Choi,et al.  Early decision in clinical trials when the treatment differences are small. Experience of a controlled trial in head trauma. , 1985, Controlled clinical trials.

[32]  S S Emerson.  Computation of the uniform minimum variance unbiased estimator of a normal mean following a group sequential trial. , 1993, Computers and biomedical research, an international journal.

[33]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[34]  K K Lan,et al.  Monitoring boundaries for adverse effects in long-term clinical trials. , 1986, Controlled clinical trials.

[35]  P K Andersen,et al.  Conditional power calculations as an aid in the decision whether to continue a clinical trial. , 1987, Controlled clinical trials.

[36]  J M Lachin,et al.  Sequential monitoring of survival data with the Wilcoxon statistic. , 1995, Biometrics.

[37]  N L Geller,et al.  The analysis of multiple endpoints in clinical trials. , 1987, Biometrics.

[38]  Max Halperin,et al.  More flexible sequential and non-sequential designs in long-term clinical trial , 1984 .

[39]  P. Thall,et al.  Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. , 1995, Statistics in medicine.

[40]  K. Bailey,et al.  Estimation and comparison of changes in the presence of informative right censoring: conditional linear model. , 1989, Biometrics.

[41]  D. Heitjan,et al.  Bayesian interim analysis of phase II cancer clinical trials. , 1997, Statistics in medicine.

[42]  D J Spiegelhalter,et al.  Application of Bayesian statistics to decision making during a clinical trial. , 1992, Statistics in medicine.

[43]  D A Follmann,et al.  Monitoring pairwise comparisons in multi-armed clinical trials. , 1994, Biometrics.

[44]  David L. DeMets,et al.  Sequential Rank Tests with Repeated Measurements in Clinical Trials , 1992 .

[45]  D A Follmann,et al.  Monitoring multi-armed trials. , 1994, Statistics in medicine.

[46]  David L. DeMets,et al.  Group sequential methods for clinical trials with a one-sided hypothesis , 1980 .

[47]  J B Kadane,et al.  Progress toward a more ethical method for clinical trials. , 1986, The Journal of medicine and philosophy.

[48]  T. Lai.  Optimal Stopping and Sequential Tests which Minimize the Maximum Expected Sample Size , 1973 .

[49]  John M. Lachin,et al.  Interim analyses with repeated measurements in a sequential clinical trial , 1990 .

[50]  T R Fleming,et al.  Symmetric group sequential test designs. , 1989, Biometrics.

[51]  J Whitehead,et al.  Sequential methods based on the boundaries approach for the clinical comparison of survival times. , 1994, Statistics in medicine.

[52]  Anastasios A. Tsiatis,et al.  Group sequential tests with censored survival data adjusting for covariates , 1985 .

[53]  Christopher Jennison,et al.  Exact calculations for sequential t, X2 and F tests , 1991 .

[54]  A L Gould,et al.  Interim analyses for monitoring clinical trials that do not materially affect the type I error rate. , 1992, Statistics in medicine.

[55]  A. Tsiatis,et al.  Approximately optimal one-parameter boundaries for group sequential trials. , 1987, Biometrics.

[56]  L. M. Berliner,et al.  Robust Bayes and Empirical Bayes Analysis with $_\epsilon$-Contaminated Priors , 1986 .

[57]  K. K. Lan,et al.  Discrete sequential boundaries for clinical trials , 1983 .

[58]  D L DeMets,et al.  Interim analysis: the alpha spending function approach. , 1994, Statistics in medicine.

[59]  J. W. Lee,et al.  Group sequential testing in clinical trials with multivariate observations: a review. , 1994, Statistics in medicine.

[60]  P. O'Brien,et al.  A multiple testing procedure for clinical trials. , 1979, Biometrics.

[61]  K Kim,et al.  Sample size determination for group sequential clinical trials with immediate response. , 1992, Statistics in medicine.

[62]  K. K. Lan,et al.  Stochastically curtailed tests in long–term clinical trials , 1982 .

[63]  Christopher Jennison,et al.  Interim analyses: the repeated confidence interval approach , 1989 .

[64]  Anastasios A. Tsiatis,et al.  Exact confidence intervals following a group sequential trial: A comparison of methods , 1988 .

[65]  David M. Reboussin,et al.  Information and information fractions for design and sequential monitoring of clinical trials , 1994 .

[66]  K Kim.  Study duration for group sequential clinical trials with censored survival data adjusting for stratification. , 1992, Statistics in medicine.

[67]  Choi Sc,et al.  Monitoring clinical trials based on predictive probability of significance. , 1989 .

[68]  J. Bernardo.  Reference Posterior Distributions for Bayesian Inference , 1979 .

[69]  D A Berry,et al.  One-sided sequential stopping boundaries for clinical trials: a decision-theoretic approach. , 1988, Biometrics.

[70]  L Wasserman,et al.  Robust Bayesian methods for monitoring clinical trials. , 1995, Statistics in medicine.

[71]  Anastasios A. Tsiatis,et al.  Group sequential designs for one-sided and two-sided hypothesis testing with provision for early stopping in favor of the null hypothesis , 1994 .

[72]  J M Lachin,et al.  Group sequential distribution-free methods for the analysis of multivariate observations. , 1992, Biometrics.

[73]  D O Scharfstein,et al.  The use of simulation and bootstrap in information-based group sequential studies. , 1998, Statistics in medicine.

[74]  David L. DeMets,et al.  Design and analysis of group sequential tests based on the type I error spending rate function , 1987 .

[75]  Michael Woodroofe,et al.  Estimation after sequential testing: A simple approach for a truncated sequential probability ratio test , 1992 .

[76]  M D Hughes,et al.  Stopping guidelines for clinical trials with multiple treatments. , 1993, Statistics in medicine.

[77]  K Kim,et al.  Study duration for clinical trials with survival response and early stopping rule. , 1990, Biometrics.

[78]  D L DeMets,et al.  Changing frequency of interim analysis in sequential monitoring. , 1989, Biometrics.

[79]  Anastasios A. Tsiatis,et al.  The asymptotic joint distribution of the efficient scores test for the proportional hazards model calculated over time , 1981 .

[80]  Christopher Jennison,et al.  Statistical Approaches to Interim Monitoring of Medical Trials: A Review and Commentary , 1990 .

[81]  Eric V. Slud,et al.  Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic , 1982 .

[82]  M C Wu,et al.  Sequential monitoring for comparison of changes in a response variable in clinical studies. , 1992, Biometrics.

[83]  Lee-Jen Wei,et al.  Combining dependent tests with incomplete repeated measurements , 1985 .

[84]  P M Fayers,et al.  Tutorial in biostatistics Bayesian data monitoring in clinical trials. , 1997, Statistics in medicine.

[85]  K K Lan,et al.  The B-value: a tool for monitoring data. , 1988, Biometrics.

[86]  D. Berry,et al.  Interim analyses in clinical trials: classical vs. Bayesian approaches. , 1985, Statistics in medicine.

[87]  P. O'Brien,et al.  Confidence intervals following group sequential tests. , 1986, Controlled clinical trials.

[88]  David L. DeMets,et al.  Asymmetric group sequential boundaries for monitoring clinical trials , 1982 .

[89]  John Whitehead,et al.  On the bias of maximum likelihood estimation following a sequential test , 1986 .

[90]  Susan Todd,et al.  Point and interval estimation following a sequential clinical trial , 1996 .

[91]  W J Shih,et al.  Design for sample size re-estimation with interim data for double-blind clinical trials with binary outcomes. , 1997, Statistics in medicine.

[92]  S G Hilsenbeck.  Early termination of a phase II clinical trial. , 1988, Controlled clinical trials.

[93]  N Stallard,et al.  Comparison of the spending function method and the Christmas tree correction for group sequential trials. , 1996, Journal of biopharmaceutical statistics.

[94]  David L. DeMets,et al.  Sequential Comparison of Changes with Repeated Measurements Data , 1991 .

[95]  J. Whitehead,et al.  A FORTRAN program for the design and analysis of sequential clinical trials. , 1983, Computers and biomedical research, an international journal.

[96]  D. Siegmund.  Corrected diffusion approximations in certain random walk problems , 1979, Advances in Applied Probability.

[97]  J. Ware,et al.  Random-effects models for longitudinal data. , 1982, Biometrics.

[98]  Eric V. Slud,et al.  Sequential Linear Rank Tests for Two-Sample Censored Survival Data , 1984 .

[99]  D. Spiegelhalter,et al.  A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. , 1986, Statistics in medicine.

[100]  Christopher Jennison,et al.  Group Sequential Analysis Incorporating Covariate Information , 1997 .

[101]  D. Berry.  Monitoring accumulating data in a clinical trial. , 1989, Biometrics.

[102]  Kung-Jong Lui.  A simple generalization of the O'Brien and Fleming group sequential test procedure to more than two treatment groups , 1993 .

[103]  D A Berry.  Decision analysis and Bayesian methods in clinical trials. , 1995, Cancer treatment and research.

[104]  K Kim,et al.  Design and analysis of group sequential logrank tests in maximum duration versus information trials. , 1995, Biometrics.

[105]  G L Rosner,et al.  A Bayesian group sequential design for a multiple arm randomized clinical trial. , 1995, Statistics in medicine.

[106]  David L. DeMets,et al.  Sequential monitoring of clinical trials with correlated responses , 1996 .

[107]  K Kim,et al.  Confidence intervals following group sequential tests in clinical trials. , 1987, Biometrics.

[108]  David L. DeMets,et al.  Stopping guidelines vs stopping rules: a practitioner's point of view , 1984 .

[109]  D J Spiegelhalter,et al.  Applying Bayesian ideas in drug development and clinical trials. , 1993, Statistics in medicine.

[110]  E. Gehan.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. , 1965, Biometrika.

[111]  J. Wolfowitz,et al.  Optimum Character of the Sequential Probability Ratio Test , 1948 .

[112]  T. Fleming,et al.  Parameter estimation following group sequential hypothesis testing , 1990 .

[113]  D L Demets,et al.  Group sequential procedures: calendar versus information time. , 1989, Statistics in medicine.

[114]  S S Emerson,et al.  A computationally simpler algorithm for the UMVUE of a normal mean following a group sequential trial. , 1997, Biometrics.

[115]  J. S. D. Cani,et al.  Group sequential designs using a family of type I error probability spending functions. , 1990, Statistics in medicine.

[116]  P. O'Brien.  Procedures for comparing samples with multiple endpoints. , 1984, Biometrics.

[117]  A A Tsiatis,et al.  Exact confidence intervals following a group sequential test. , 1984, Biometrics.

[118]  T R Fleming,et al.  Designs for group sequential tests. , 1984, Controlled clinical trials.

[119]  J M Lachin,et al.  Termination of a clinical trial with no treatment group difference: the Lupus Nephritis Collaborative Study. , 1992, Controlled clinical trials.

[120]  Michael A. Proschan,et al.  Effects of assumption violations on type I error rate in group sequential monitoring , 1992 .

[121]  S. Pocock,et al.  Stopping rules and estimation problems in clinical trials. , 1988, Statistics in medicine.

[122]  A Fletcher,et al.  Implications for trials in progress of publication of positive results , 1993, The Lancet.

[123]  M. Schervish.  Multivariate normal probabilities with error bound , 1984 .

[124]  M H Gail,et al.  Use of logrank tests and group sequential methods at fixed calendar times. , 1985, Biometrics.

[125]  S. Snapinn,et al.  Monitoring clinical trials with a conditional probability stopping rule. , 1992, Statistics in medicine.

[126]  P. Armitage,et al.  Sequential methods in clinical trials. , 1958, American journal of public health and the nation's health.

[127]  B W Turnbull,et al.  Group sequential tests for bivariate response: interim analyses of clinical trials with both efficacy and safety endpoints. , 1993, Biometrics.

[128]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[129]  James M. Robins,et al.  Semiparametric Efficiency and its Implication on the Design and Analysis of Group-Sequential Studies , 1997 .

[130]  N. Cressie,et al.  A sample-size-optimal Bayesian procedure for sequential pharmaceutical trials. , 1994, Biometrics.

[131]  T. Fearn,et al.  Bayesian statistics : principles, models, and applications , 1990 .

[132]  J M Lachin,et al.  Implementation of group sequential logrank tests in a maximum duration trial. , 1990, Biometrics.

[133]  D. Siegmund.  Estimation following sequential tests , 1978 .

[134]  D. Schoenfeld.  The asymptotic properties of nonparametric tests for comparing survival distributions , 1981 .

[135]  P. Diggle,et al.  Analysis of Longitudinal Data , 2003 .

[136]  D. Siegmund.  Sequential Analysis: Tests and Confidence Intervals , 1985 .

[137]  R A Betensky,et al.  Sequential analysis of censored survival data from three treatment groups. , 1997, Biometrics.

[138]  David J. Spiegelhalter,et al.  Bayesian Approaches to Randomized Trials , 1994, Bayesian Biostatistics.

[139]  R Simon,et al.  A decade of progress in statistical methodology for clinical trials. , 1991, Statistics in medicine.

[140]  D J Spiegelhalter,et al.  A unified method for monitoring and analysing controlled trials. , 1994, Statistics in medicine.

[141]  P. Armitage,et al.  Repeated Significance Tests on Accumulating Data , 1969 .

[142]  P Gustafson,et al.  Robustness considerations in Bayesian analysis , 1996, Statistical methods in medical research.

[143]  D J Spiegelhalter,et al.  The what, why and how of Bayesian clinical trials monitoring. , 1994, Statistics in medicine.

[144]  R. Prentice.  Linear rank tests with right censored data , 1978 .

[145]  M. Chang,et al.  Confidence intervals for a normal mean following a group sequential test. , 1989, Biometrics.